These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2591384)

  • 21. Increased pain reactions as hang-over phenomena after intra-arterial injections of contrast media in rats.
    Hagen B; Siefert HM; Mützel W; Speck U
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():57-61. PubMed ID: 6139081
    [No Abstract]   [Full Text] [Related]  

  • 22. Phase II studies in urography, cardioangiography and cerebral angiography with iohexol. An evaluation of the clinical trial program and the clinical findings.
    Andrew E; Sveen K; Renaa T; Dahlstrøm K
    Eur J Radiol; 1983 Aug; 3(3):194-201. PubMed ID: 6628397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous ionic contrast media cause local prostacyclin release in man.
    De Maeyer P; Deckmyn H; Arnout J; Baert AL; Vermylen J
    Invest Radiol; 1985 Nov; 20(8):871-3. PubMed ID: 3908384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of sodium addition to non-ionic contrast media on cardiac contractile force. Perfusion of the isolated rabbit heart with iohexol and iopentol containing 0 to 154 mmol Na+/l added as NaCl.
    Bååth L; Almén T; Oksendal A
    Acta Radiol; 1990 Jan; 31(1):99-104. PubMed ID: 2340228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast medium tolerance in computed tomography.
    Tschakert H
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():156-61. PubMed ID: 6139072
    [No Abstract]   [Full Text] [Related]  

  • 26. [Injection cholecystography--influence of radiopaque substance and injection time on the excretion of contrast media and incidence of side effects].
    Schmerwitz W
    Rontgenblatter; 1977 Feb; 30(2):64-70. PubMed ID: 576504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experiment compared between iodoxamidic acid and ioglycamic acid, in flasks drop by drop. Observations of adverse reactions].
    Viviani G; Mozzanica C; Pozzoli P
    J Radiol Electrol Med Nucl; 1975; 56 suppl 2():548. PubMed ID: 1243924
    [No Abstract]   [Full Text] [Related]  

  • 28. Summary of U.S. and European intravascular experience with iohexol based on the clinical trial program.
    Dahlstrom K; Shaw DD; Clauss W; Andrew E; Sveen K
    Invest Radiol; 1985; 20(1 Suppl):S117-21. PubMed ID: 3882613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind CT study comparing the safety and efficacy of iopentol and ioxaglate in paediatric patients.
    Sayegh N; Porée C; Baraton J; Skinningsrud K; Nantois C; Lallemand D
    Eur Radiol; 1996; 6(4):574-7. PubMed ID: 8798046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and pharmacokinetics of ioversol in healthy volunteers.
    Wilkins RA; Whittington JR; Brigden GS; Lahiri A; Heber ME; Hughes LO
    Invest Radiol; 1989 Oct; 24(10):781-8. PubMed ID: 2793391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular and electrocardiographic effects of iopentol in left ventricular angiography. Comparison of the low-osmolar, non-ionic iopentol (Imagopaque 350) and the hyper-osmolar, ionic metrizoate meglumine-Na-Ca (Isopaque Coronar 370) in patients with coronary heart disease.
    Vik-Mo H; Danielsen R; Skinningsrud K; Haider T; Bjørkhaug A
    Eur Radiol; 1997; 7 Suppl 4():S156-61. PubMed ID: 9204361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of intravenous cholangio-cholecystography with a meglumine salt of iodoxamic acid with research on fibrinolysis].
    Macchi C; Fiore D; Miotto D; Cella G; Bidoli F
    J Radiol Electrol Med Nucl; 1975; 56 suppl 2():549-50. PubMed ID: 1243925
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical trial program for iopentol. A new nonionic ratio 3.0 contrast medium with emphasis on clinical phases I and II.
    Andrew E; Waaler A; Jakobsen J; Holager T; Lambrechts M; Moxnes A; Kruger Hagen E; Bach-Gansmo T
    Invest Radiol; 1988 Sep; 23 Suppl 1():S189-92. PubMed ID: 3058629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intraventricular contrast medium (non-ionic water soluble dimer) residue a month after injection; a case report].
    Kawata Y; Suzuki T; Ebina K; Sugawara A; Hirano T
    Rinsho Hoshasen; 1990 Jun; 35(6):729-32. PubMed ID: 2388411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A contribution to the rate of side-effects of hepatotropic contrast media. A clinical comparative study of iodoxamate (Endomirabil) and ioglycamid (Bilivistan) (author's transl)].
    Kölling K; Hoenle R; Korsten FW
    Radiologe; 1977 Feb; 17(2):70-3. PubMed ID: 322198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iopentol (Imagopaque 350) compared with diatrizoate (Urografin 370) in cerebral CT. A clinical trial assessing immediate and late (7 days) adverse events and diagnostic information (visualization quality and Hounsfield unit measurements).
    Valentine A; Jakobsen JA; Klaveness AJ
    Eur Radiol; 1997; 7 Suppl 4():S145-8. PubMed ID: 9204358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Endomirabil, a new contrast medium for the biliary tract. Rate of adverse effects with special reference to the application time].
    Barner L; Kurzen S
    Med Welt; 1977 Apr; 28(17):817-9. PubMed ID: 577589
    [No Abstract]   [Full Text] [Related]  

  • 38. Iopentol (Imagopaque 300 and 350) compared with iohexol (Omnipaque 300 and 350) in cerebral and aortic arch angiography. A clinical trial assessing adverse events and diagnostic information.
    Ericsson K; Bjartveit K
    Eur Radiol; 1997; 7 Suppl 4():S152-5. PubMed ID: 9204360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular side effects of various conventional, low-osmolar and non-ionic contrast media.
    Wink K; Wissert J
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():120-4. PubMed ID: 6139066
    [No Abstract]   [Full Text] [Related]  

  • 40. Safety and tolerability of iodixanol in healthy volunteers with reference to two monomeric X-ray contrast media.
    Jørgensen NP; Nossen JO; Borch KW; Kristiansen AB; Kristoffersen DT; Lundby B; Theodorsen L
    Eur J Radiol; 1992 Oct; 15(3):252-7. PubMed ID: 1490453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.